Skip to main content

Standard Industries to acquire Grace

27th April 2021

Submitted by:

Andrew Warmington

A five-month battle over the ownership of W. R. Grace & Co. came to an end on 26 April, when the company entered into a definitive agreement with Standard Industries Holdings will acquire it in an all-cash transaction valued at approximately $7.0 billion. This includes Grace’s pending acquisition of Albemarle Fine Chemistry Services (FCS).

Closing is expected to take place in Q4. This is subject to customary closing conditions, including approval by Grace shareholders and certain regulatory approvals, but is not contingent upon financing. Grace will then become a private company and will be delisted from the New York Stock Exchange. It will continue to operate as a stand-alone entity.

“Standard’s $7 billion investment in Grace reflects their confidence in the significant growth opportunities we have and enables our shareholders to realise immediate value at a significant cash premium,” commented Hudson La Force, Grace’s president and CEO.

Standard is the parent company of global industrial company Standard Industries, which includes GAF, BMI Group, Schiedel, Siplast, SGI and GAF Energy and operates in 80 countries, with 15,000 employees. Via its investment platform, 40 North, it already held 14.9% of Grace when it offered $60/share for the company on 6 November 2020.

Standard said that this was “the most credible path to unlock value for the company and its shareholders with a high level of certainty”. The Grace board unanimously rejected this, asserting that the offer “significantly undervalues the company and is not a basis for further discussion”. At the time, Grace was trading at $44.05/share.

In January, 40 North returned with an offer of $65/share. Grace replied that it was open to a sale providing that a transaction reflected its “full value”. Shortly after this, Grace agreed to acquire Albermarle FCS for $750 million, which 40 North described as “questionably-timed”. There was also a brief war of words, with 40 North claiming that its ability to conduct due diligence had been hindered by the limited information provided by Grace.

After a standstill agreement was reached that gave Grace time to seek other buyers, 40 North made what it described as its “best and final” offer of $70/share on 7 April. Signs that the parties were inching towards agreement emerged a week later, when they agreed to extend the nomination deadline for 40 North to submit director candidates for Grace’s board of directors at its 2021 shareholder AGM by 11 days to 26 April.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Qore's 1,4-BDO facility at Eddyville

Qore launches biobased 14-BDO

Cargill-Helm joint venture Qore has completed a $300 million facility at Eddyville, Iowa, that will make 66,000

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington